Facility Location
|
FACWIDEIN Facility-wide Inpatient (FacWIDEIn) |
Number of patient days |
100 d |
Number of admissions |
20 |
Number of patient days adjusted for C. difficile reporting (for inpatient location) |
20 d |
Number of admissions adjusted for C.Diff reporting |
10 |
Number of patient days adjusted for MDRO reporting (for inpatient location) |
20 d |
Number of admissions adjusted for MDRO reporting (for inpatient location) |
10 |
Number of observations in which hand hygiene was indicated |
30 |
Number of observations in which hand hygiene was performed |
30 |
Number of observations in which the use of gown and gloves was indicated |
30 |
Number of observations in which gown and gloves were used |
30 |
Active surveillance testing (AST) organism monitored |
Methicillin resistant Staphylococcus aureus (organism) |
Timing of active surveillance testing (AST) |
On admission only |
Active surveillance testing (AST) eligible patients |
All patients |
Number of patients eligible for monitoring at admission/transfer in |
20 |
Number of patients on which monitoring was performed at admission/transfer in |
19 |
Number of patients eligible for monitoring at discharge/transfer out |
15 |
Number of patients on which monitoring was performed at discharge/transfer out |
15 |
Prevalent cases identified (clinical positive) |
2 |
Prevalent cases previously known |
0 |
Incident cases |
0 |
C. difficile primary testing method used most often for this quarter |
GDHNAAT - GDH plus NAAT |
Inpatient Rehabilitation (IRF) Unit in Facility |
Yes |
Inpatient Psychiatric (IPF) Unit in Facility |
No |